CALLIE BELL: Open Payments
NPI 1588425995 · GREENVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$807 in 38 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $807
Food & beverage: $807
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $142 |
| Novartis Pharmaceuticals Corporation | 5 | $113 |
| Amgen Inc. | 6 | $107 |
| Merck Sharp & Dohme LLC | 6 | $104 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $94 |
| ABIOMED | 2 | $40 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $33 |
| SCPHARMACEUTICALS INC. | 1 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
Products named: OPDIVO, LEQVIO, REPATHA, VERQUVO, JARDIANCE, Kerendia, LifeVest, FUROSCIX.
Industry payments across KY — which companies pay providers there.
